[1] Attele AS, Wu JA, Yuan CS.Ginseng pharmacology: multiple constituents and multiple actions[J].Biochem Pharmacol, 1999, 58(11):1685-1693. [2] 候明晓, 敖定椿.人参总皂苷抗心肌缺血-再灌注损伤的作用机制[J].中国胸心血管外科临床杂志, 2000, 7(4):256-259. [3] Chen X.Cardiovascular protection by ginsenosides and their nitric oxide releasing action[J].Clin Exp Pharmacol Physiol, 1996, 23(8):728-732. [4] Sugden PH.Signaling pathways in cardiac myoeyte hypertrophy[ J].AnnMed, 2001,33(9):611-622. [5] Kempf T, Wollert KC.Nitric oxide and the enigma of cardiac hypertrophy[J].Bio Essays, 2004, 26(6):608-615. [6] Jiang QS, Huang XN, Dai ZK, et al.Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat[J].J Ethnopharmacol, 2007, 111(3): 567-572. [7] Jiang QS, Huang XN, Yang GZ, et al.Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyoeyte hypertrophy induced by prostaglandin F2α[J]. Acta Pharmacol Sin, 2007, 28(8):1149-1154. [8] Anversa P, Hagopian M, Loud AV.Quantitative radioautographic localization of protein synthesis in experimental cardiac hypertrophy[J].Lab Invest, 1973, 29(3):282-292. [9] 焦阳, 洪小苏, 陈建昌.降压药物对未成年自发性高血压大鼠心肌细胞凋亡的影响[J].高血压杂志, 2003, 11(5):468-472. [10] 胡硕强, 黄德嘉.肥厚心肌电生理学特性及其离子机制的研究进展[J].中国心脏起搏与心电生理杂志, 2003, 17(4):311-314. [11] Esposito G, Rapacciuolo A, Naga Prasad SV, et al.Genetic alterations that inhibit in vivo pressure overload hypertrophy prevent cardiac dysfunction despite increased wall stress[J].Circulation, 2002, 105(1):85-92. [12] Frey N, Olson EN.Cardiac hypertrophy:the good, the bad, and the agly[J].Ann Rev Physiol, 2003, 65:45-79. [13] Zhang R, Crump J, Reisin E.Regression of left ventricular hypertrophy is a key goal of hypertension management[J].Curr Hypertens Rep, 2003, 5(4):301-308. [14] 蒋青松, 黄燮南, 周歧新.钙调神经磷酸酶在L-精氨酸抗心肌肥厚重的作用[J].中国药理学通报, 2007, 23(9):1218-1223. [15] Lai J, Jin H, Yan R, et al.Prostag-landin F2α induceds cardiac hypertrophy in vitro and cardiac growth in vivo[J].Am J physiol, 1996, 271(Heart Circ.Physiol.40): H2197-H2208. [16] Zhang W.Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy[J].Cardiovasc Res, 2002, 53(2):294-303. |